Galapagos Company

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Industry: AI, Clinical Development
Headquarters: Mechelen-bovelingen, Limburg, Belgium
Founded Date: 1999-01-01
Employees Number: 251-500
Funding Status: IPO
Investors Number: 6
Total Funding: 5446287155
Estimated Revenue: $100M to $500M
Last Funding Date: 2019-07-14
Last Funding Type: Post-IPO Equity

Visit Website
dpo@glpg.com
https://twitter.com/GalapagosNV
Register and Claim Ownership